A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells

Elife. 2022 Apr 22:11:e72313. doi: 10.7554/eLife.72313.

Abstract

To identify roles of RNA binding proteins (RBPs) in the differentiation or survival of antibody secreting plasma cells we performed a CRISPR/Cas9 knockout screen of 1213 mouse RBPs for their ability to affect proliferation and/or survival, and the abundance of differentiated CD138 + cells in vitro. We validated the binding partners CSDE1 and STRAP as well as the m6A binding protein YTHDF2 as promoting the accumulation of CD138 + cells in vitro. We validated the EIF3 subunits EIF3K and EIF3L and components of the CCR4-NOT complex as inhibitors of CD138 + cell accumulation in vitro. In chimeric mouse models YTHDF2-deficient plasma cells failed to accumulate.

Keywords: B cell; RNA binding protein; antibody secreting cell; developmental biology; immunology; inflammation; mouse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier Proteins
  • Mice
  • Plasma Cells*
  • RNA-Binding Proteins* / genetics
  • RNA-Binding Proteins* / metabolism

Substances

  • Carrier Proteins
  • RNA-Binding Proteins

Associated data

  • GEO/GSE179919
  • GEO/GSE179281